Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-05 @ 5:50 PM
Study NCT ID:
NCT03035032
Status:
COMPLETED
Last Update Posted:
2024-11-26
First Post:
2017-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients
Sponsor:
Astellas Pharma Singapore Pte. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-23
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-19
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-25
First Submit QC Date:
None
Study First Post Date:
2017-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-11-13
Results First Submit QC Date:
None
Results First Post Date:
2020-12-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-08
Last Update Post Date:
2024-11-26
Last Update Post Date Type:
ACTUAL